PET quantification of the norepinephrine transporter in human brain with (S,S)-18F-FMeNER-D2

Sho Moriguchi, Yasuyuki Kimura, Masanori Ichise, Ryosuke Arakawa, Harumasa Takano, Chie Seki, Yoko Ikoma, Keisuke Takahata, Tomohisa Nagashima, Makiko Yamada, Masaru Mimura, Tetsuya Suhara

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Norepinephrine transporter (NET) in the brain plays important roles in human cognition and the pathophysiology of psychiatric disorders. Two radioligands, (S,S)-11C-MRB and (S,S)-18F-FMeNER-D2, have been used for imaging NETs in the thalamus and midbrain (including locus coeruleus) using PET in humans. However, NET density in the equally important cerebral cortex has not been well quantified because of unfavorable kinetics with (S,S)-11C-MRB and defluorination with (S,S)-18F-FMeNERD2, which can complicate NET quantification in the cerebral cortex adjacent to the skull containing defluorinated 18F radioactivity. In this study, we have established analysis methods of quantification of NET density in the brain including the cerebral cortex using (S,S)-18F-FMeNER-D2 PET. Methods: We analyzed our previous (S,S)-18F-FMeNER-D2 PET data of 10 healthy volunteers dynamically acquired for 240min with arterial blood sampling. The effects of defluorination on the NET quantification in the superficial cerebral cortex was evaluated by establishing a time stability of NET density estimations with an arterial input 2-tissue-compartment model, which guided the less-invasive reference tissue model and area under the time-activity curve methods to accurately quantify NET density in all brain regions including the cerebral cortex. Results: Defluorination of (S,S)-18F-FMeNER-D2 became prominent toward the latter half of the 240-min scan. Total distribution volumes in the superficial cerebral cortex increased with the scan duration beyond 120 min. We verified that 90-min dynamic scans provided a sufficient amount of data for quantification of NET density unaffected by defluorination. Reference tissue model binding potential values from the 90-min scan data and area under the time-activity curve ratios of 70-to 90-min data allowed for the accurate quantification of NET density in the cerebral cortex. Conclusion: We have established methods of quantification of NET densities in the brain including the cerebral cortex unaffected by defluorination using (S,S)-18FFMeNER-D2. These results suggest that we can accurately quantify NET density with a 90-min (S,S)-18F-FMeNER-D2 scan in broad brain areas.

Original languageEnglish
Pages (from-to)1140-1145
Number of pages6
JournalJournal of Nuclear Medicine
Volume58
Issue number7
DOIs
Publication statusPublished - 2017 Jul 1

Fingerprint

Norepinephrine Plasma Membrane Transport Proteins
Cerebral Cortex
Brain
2-(alpha-(2-fluoromethoxyphenoxy)benzyl)morpholine
Locus Coeruleus
Mesencephalon
Thalamus
Skull
Radioactivity
Cognition
Psychiatry
Healthy Volunteers

Keywords

  • (S
  • Cerebral cortex
  • Norepinephrine transporter
  • Positron emission tomography
  • S)-F-FMeNER-D

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Moriguchi, S., Kimura, Y., Ichise, M., Arakawa, R., Takano, H., Seki, C., ... Suhara, T. (2017). PET quantification of the norepinephrine transporter in human brain with (S,S)-18F-FMeNER-D2 Journal of Nuclear Medicine, 58(7), 1140-1145. https://doi.org/10.2967/jnumed.116.178913

PET quantification of the norepinephrine transporter in human brain with (S,S)-18F-FMeNER-D2 . / Moriguchi, Sho; Kimura, Yasuyuki; Ichise, Masanori; Arakawa, Ryosuke; Takano, Harumasa; Seki, Chie; Ikoma, Yoko; Takahata, Keisuke; Nagashima, Tomohisa; Yamada, Makiko; Mimura, Masaru; Suhara, Tetsuya.

In: Journal of Nuclear Medicine, Vol. 58, No. 7, 01.07.2017, p. 1140-1145.

Research output: Contribution to journalArticle

Moriguchi, S, Kimura, Y, Ichise, M, Arakawa, R, Takano, H, Seki, C, Ikoma, Y, Takahata, K, Nagashima, T, Yamada, M, Mimura, M & Suhara, T 2017, 'PET quantification of the norepinephrine transporter in human brain with (S,S)-18F-FMeNER-D2 ', Journal of Nuclear Medicine, vol. 58, no. 7, pp. 1140-1145. https://doi.org/10.2967/jnumed.116.178913
Moriguchi, Sho ; Kimura, Yasuyuki ; Ichise, Masanori ; Arakawa, Ryosuke ; Takano, Harumasa ; Seki, Chie ; Ikoma, Yoko ; Takahata, Keisuke ; Nagashima, Tomohisa ; Yamada, Makiko ; Mimura, Masaru ; Suhara, Tetsuya. / PET quantification of the norepinephrine transporter in human brain with (S,S)-18F-FMeNER-D2 In: Journal of Nuclear Medicine. 2017 ; Vol. 58, No. 7. pp. 1140-1145.
@article{b4ac164620a445d386c4a17c3b1ca393,
title = "PET quantification of the norepinephrine transporter in human brain with (S,S)-18F-FMeNER-D2",
abstract = "Norepinephrine transporter (NET) in the brain plays important roles in human cognition and the pathophysiology of psychiatric disorders. Two radioligands, (S,S)-11C-MRB and (S,S)-18F-FMeNER-D2, have been used for imaging NETs in the thalamus and midbrain (including locus coeruleus) using PET in humans. However, NET density in the equally important cerebral cortex has not been well quantified because of unfavorable kinetics with (S,S)-11C-MRB and defluorination with (S,S)-18F-FMeNERD2, which can complicate NET quantification in the cerebral cortex adjacent to the skull containing defluorinated 18F radioactivity. In this study, we have established analysis methods of quantification of NET density in the brain including the cerebral cortex using (S,S)-18F-FMeNER-D2 PET. Methods: We analyzed our previous (S,S)-18F-FMeNER-D2 PET data of 10 healthy volunteers dynamically acquired for 240min with arterial blood sampling. The effects of defluorination on the NET quantification in the superficial cerebral cortex was evaluated by establishing a time stability of NET density estimations with an arterial input 2-tissue-compartment model, which guided the less-invasive reference tissue model and area under the time-activity curve methods to accurately quantify NET density in all brain regions including the cerebral cortex. Results: Defluorination of (S,S)-18F-FMeNER-D2 became prominent toward the latter half of the 240-min scan. Total distribution volumes in the superficial cerebral cortex increased with the scan duration beyond 120 min. We verified that 90-min dynamic scans provided a sufficient amount of data for quantification of NET density unaffected by defluorination. Reference tissue model binding potential values from the 90-min scan data and area under the time-activity curve ratios of 70-to 90-min data allowed for the accurate quantification of NET density in the cerebral cortex. Conclusion: We have established methods of quantification of NET densities in the brain including the cerebral cortex unaffected by defluorination using (S,S)-18FFMeNER-D2. These results suggest that we can accurately quantify NET density with a 90-min (S,S)-18F-FMeNER-D2 scan in broad brain areas.",
keywords = "(S, Cerebral cortex, Norepinephrine transporter, Positron emission tomography, S)-F-FMeNER-D",
author = "Sho Moriguchi and Yasuyuki Kimura and Masanori Ichise and Ryosuke Arakawa and Harumasa Takano and Chie Seki and Yoko Ikoma and Keisuke Takahata and Tomohisa Nagashima and Makiko Yamada and Masaru Mimura and Tetsuya Suhara",
year = "2017",
month = "7",
day = "1",
doi = "10.2967/jnumed.116.178913",
language = "English",
volume = "58",
pages = "1140--1145",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "7",

}

TY - JOUR

T1 - PET quantification of the norepinephrine transporter in human brain with (S,S)-18F-FMeNER-D2

AU - Moriguchi, Sho

AU - Kimura, Yasuyuki

AU - Ichise, Masanori

AU - Arakawa, Ryosuke

AU - Takano, Harumasa

AU - Seki, Chie

AU - Ikoma, Yoko

AU - Takahata, Keisuke

AU - Nagashima, Tomohisa

AU - Yamada, Makiko

AU - Mimura, Masaru

AU - Suhara, Tetsuya

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Norepinephrine transporter (NET) in the brain plays important roles in human cognition and the pathophysiology of psychiatric disorders. Two radioligands, (S,S)-11C-MRB and (S,S)-18F-FMeNER-D2, have been used for imaging NETs in the thalamus and midbrain (including locus coeruleus) using PET in humans. However, NET density in the equally important cerebral cortex has not been well quantified because of unfavorable kinetics with (S,S)-11C-MRB and defluorination with (S,S)-18F-FMeNERD2, which can complicate NET quantification in the cerebral cortex adjacent to the skull containing defluorinated 18F radioactivity. In this study, we have established analysis methods of quantification of NET density in the brain including the cerebral cortex using (S,S)-18F-FMeNER-D2 PET. Methods: We analyzed our previous (S,S)-18F-FMeNER-D2 PET data of 10 healthy volunteers dynamically acquired for 240min with arterial blood sampling. The effects of defluorination on the NET quantification in the superficial cerebral cortex was evaluated by establishing a time stability of NET density estimations with an arterial input 2-tissue-compartment model, which guided the less-invasive reference tissue model and area under the time-activity curve methods to accurately quantify NET density in all brain regions including the cerebral cortex. Results: Defluorination of (S,S)-18F-FMeNER-D2 became prominent toward the latter half of the 240-min scan. Total distribution volumes in the superficial cerebral cortex increased with the scan duration beyond 120 min. We verified that 90-min dynamic scans provided a sufficient amount of data for quantification of NET density unaffected by defluorination. Reference tissue model binding potential values from the 90-min scan data and area under the time-activity curve ratios of 70-to 90-min data allowed for the accurate quantification of NET density in the cerebral cortex. Conclusion: We have established methods of quantification of NET densities in the brain including the cerebral cortex unaffected by defluorination using (S,S)-18FFMeNER-D2. These results suggest that we can accurately quantify NET density with a 90-min (S,S)-18F-FMeNER-D2 scan in broad brain areas.

AB - Norepinephrine transporter (NET) in the brain plays important roles in human cognition and the pathophysiology of psychiatric disorders. Two radioligands, (S,S)-11C-MRB and (S,S)-18F-FMeNER-D2, have been used for imaging NETs in the thalamus and midbrain (including locus coeruleus) using PET in humans. However, NET density in the equally important cerebral cortex has not been well quantified because of unfavorable kinetics with (S,S)-11C-MRB and defluorination with (S,S)-18F-FMeNERD2, which can complicate NET quantification in the cerebral cortex adjacent to the skull containing defluorinated 18F radioactivity. In this study, we have established analysis methods of quantification of NET density in the brain including the cerebral cortex using (S,S)-18F-FMeNER-D2 PET. Methods: We analyzed our previous (S,S)-18F-FMeNER-D2 PET data of 10 healthy volunteers dynamically acquired for 240min with arterial blood sampling. The effects of defluorination on the NET quantification in the superficial cerebral cortex was evaluated by establishing a time stability of NET density estimations with an arterial input 2-tissue-compartment model, which guided the less-invasive reference tissue model and area under the time-activity curve methods to accurately quantify NET density in all brain regions including the cerebral cortex. Results: Defluorination of (S,S)-18F-FMeNER-D2 became prominent toward the latter half of the 240-min scan. Total distribution volumes in the superficial cerebral cortex increased with the scan duration beyond 120 min. We verified that 90-min dynamic scans provided a sufficient amount of data for quantification of NET density unaffected by defluorination. Reference tissue model binding potential values from the 90-min scan data and area under the time-activity curve ratios of 70-to 90-min data allowed for the accurate quantification of NET density in the cerebral cortex. Conclusion: We have established methods of quantification of NET densities in the brain including the cerebral cortex unaffected by defluorination using (S,S)-18FFMeNER-D2. These results suggest that we can accurately quantify NET density with a 90-min (S,S)-18F-FMeNER-D2 scan in broad brain areas.

KW - (S

KW - Cerebral cortex

KW - Norepinephrine transporter

KW - Positron emission tomography

KW - S)-F-FMeNER-D

UR - http://www.scopus.com/inward/record.url?scp=85021812946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021812946&partnerID=8YFLogxK

U2 - 10.2967/jnumed.116.178913

DO - 10.2967/jnumed.116.178913

M3 - Article

C2 - 27980046

AN - SCOPUS:85021812946

VL - 58

SP - 1140

EP - 1145

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 7

ER -